Bone Biologics reported earnings of -$ 0.17 per BBLG share on Oct 26, 2026, falling short of analysts' expectations by
| Report Date | Oct 26, 2026 |
|---|---|
| Forecasted EPS | -$ 0.19 |
| Earnings Per Share (Surprise) | -$ 0.17 (+$ 0.02) |
| Last Year's EPS | -$ 0.90 |
| EPS YoY Change |
Out of the last 49 earnings reporting periods, Bone Biologics beat analysts’ expectations 13 times and fell short of expectations 8 time(s). Bone Biologics reported earnings per share of -$ 0.17 in the last report surpassing an estimated EPS of -$ 0.19 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Oct 26, 2026 | -$ 0.19 | -$ 0.17 | -$ 0.37 | |
| Aug 14, 2026 | -$ 0.43 | -$ 0.43 | -$ 1.33 | |
| May 14, 2026 | -$ 0.43 | -$ 0.43 | -$ 0.32 | |
| Mar 2, 2026 | -$ 0.34 | -$ 0.58 | -$ 1.92 | |
| Nov 14, 2025 | -$ 1.23 | -$ 0.37 | -$ 0.48 | |
| Aug 14, 2025 | -$ 0.58 | -$ 1.33 | -$ 2.37 | |
| May 13, 2025 | -$ 3.24 | -$ 0.32 | -$ 0.67 | |
| May 12, 2025 | -$ 0.48 | -$ 1.92 | -$ 7.86 | |
| Mar 5, 2025 | -$ 0.65 | -$ 0.48 | -$ 7.86 | |
| Nov 14, 2024 | -$ 3.60 | -$ 2.37 | -$ 2.47 | |
| Aug 9, 2024 | -$ 1.39 | -$ 0.67 | -$ 2.47 | |
| May 14, 2024 | -$ 45.59 | -$ 7.86 | -$ 29.27 | |
| May 13, 2024 | -$ 7.60 | -$ 7.86 | -$ 81.10 | |
| Apr 4, 2024 | -$ 5.60 | -$ 2.47 | -$ 331.47 | |
| Mar 18, 2024 | -$ 5.60 | -$ 2.47 | $ 144.12 | |
| Nov 14, 2023 | -$ 3.04 | -$ 29.27 | -$ 12.00 | |
| Aug 14, 2023 | -$ 71.99 | -$ 81.10 | -$ 10.88 | |
| May 15, 2023 | -$ 2,161.73 | -$ 331.47 | -$ 15.99 | |
| Mar 30, 2023 | -$ 69.60 | $ 144.12 | -$ 4.13 | |
| Nov 14, 2022 | -$ 0.25 | -$ 12.00 | -$ 9.95 |
Bone Biologics’s stock was trading at $ 0.3948 on Oct 25, 2026 a day before the last earnings report was released.Following the release of the earnings report, BBLG’s price decreased to $ 0.368 on Oct 27, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Oct 26, 2026 | -$ 0.17 | $ 0.3948 | $ 0.368 | |
| Aug 14, 2026 | -$ 0.43 | $ 0.6743 | $ 0.66 | |
| May 14, 2026 | -$ 0.43 | $ 1.30 | $ 1.27 | |
| Mar 2, 2026 | -$ 0.58 | $ 1.15 | $ 1.26 | |
| Nov 14, 2025 | -$ 0.37 | $ 1.70 | $ 1.63 | |
| Aug 14, 2025 | -$ 1.33 | $ 2.35 | $ 2.20 | |
| May 13, 2025 | -$ 0.32 | $ 4.38 | $ 4.44 | |
| May 12, 2025 | -$ 1.92 | $ 4.50 | $ 4.65 | |
| Mar 5, 2025 | -$ 0.48 | $ 4.76 | $ 5.04 | |
| Nov 14, 2024 | -$ 2.37 | $ 7.08 | $ 7.14 | |
| Aug 9, 2024 | -$ 0.67 | $ 9.54 | $ 9.72 | |
| May 14, 2024 | -$ 7.86 | $ 11.40 | $ 13.62 | |
| May 13, 2024 | -$ 7.86 | $ 11.52 | $ 13.80 | |
| Apr 4, 2024 | -$ 2.47 | $ 11.76 | $ 10.38 | |
| Mar 18, 2024 | -$ 2.47 | $ 13.98 | $ 14.40 | |
| Nov 14, 2023 | -$ 29.27 | $ 24.00 | $ 26.04 | |
| Aug 14, 2023 | -$ 81.10 | $ 61.44 | $ 39.00 | |
| May 15, 2023 | -$ 331.47 | $ 136.98 | $ 139.02 | |
| Mar 30, 2023 | $ 144.12 | $ 180.18 | $ 186.30 | |
| Nov 14, 2022 | -$ 12.00 | $ 216.18 | $ 231.72 |
Bone Biologics released its most recent earnings reports in October 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Bone Biologics beat analysts’ expectations during the last earnings period by
